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Burn wound is one of the main causes of disability and 
mortality in human, which imposes severe economic and 
social consequences on community, particularly in developing 
Background: Burn wound is an important cause of morbidity and mortality worldwide. Improving the host’s immune system and removing the 
infection can be effective in healing wounds caused by burns. Granulocyte-colony-stimulating factor (G-CSF) stimulates both the bone marrow to 
produce granulocytes and the function of neutrophil precursors. The aim of this study was to examine the effect of G-CSF on removing infection 
and healing wound. Materials and Methods: A burn model was used to induce burns in 18 adult Balb/c mice, and their wounds were infected 
by Acinetobacter baumannii strains. Burned mice were divided into two groups (control and G-CSF) and treated daily by subcutaneous injections 
of normal saline (0.1 mL) and G-CSF (10 µg/kg). The wound healing process was evaluated by the morphological and histological assessments. 
Results: In morphological assay, the mean size of the wounds in the 3rd and 7th days of the treatment was significantly lower in the G-CSF treated 
group compared to the control group. Some of the histological parameters were evaluated, including the level of inflammation, re-epithelialization, 
angiogenesis, collagen deposition, the amount of granulation tissue, and fibroblast maturation. The results showed that inflammation was reduced 
in the G-CSF-treated group, and re-epithelialization and collagen deposition were increased insignificantly compared to the normal saline-treated 
group. Furthermore, bacterial translocation was reduced significantly in the G-CSF-treated group. Conclusion: G-CSF enhances wound closure 
and helps in wound healing by improving the immune system. It has also an anti-inflammatory role and reduces bacterial translocation.
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countries.[1,2] Infection is considered as the common feature of 
burns because skin, which acts as a protective layer against 
microbes, is damaged in burns.[1] In addition, the immune system 
weakens in the burns, and the body becomes susceptible to 
various infections and sepsis.[2,3] Some studies have reported 
that bacterial translocation occurs after some types of stress, 
thermal injury, significant trauma, host immune deficiencies, 
immunosuppression, disruption of the ecologic gastrointestinal 
equilibrium to allow intestinal bacterial overgrowth, and 
increased permeability of the intestinal mucosal barrier.[4] It 
is the invasion of gastrointestinal tract flora bacteria and their 
toxins which normally sterile tissues and the extraintestinal 
sites such as the mesenteric lymph nodes, liver, spleen, kidney, 
and bloodstream.[3,4] Evidence suggests that translocation of 
indigenous bacteria from the gastrointestinal tract is an important 
early step in the pathogenesis of opportunistic infections 
originating from the gastrointestinal tract.[4] Acinetobacter 
baumannii (Ab) is the common bacterium in nosocomial 
burn wound infections[5,6] because multidrug-resistant (MDR) 
Ab strains have increased in recent years.[4,5] Therefore, 
it is necessary to find new therapeutic drugs to prevent 
bacterial translocation, improve host’s immune system, and 
remove infection in burns.[7] Granulocyte-colony-stimulating 
factor (G-CSF), produced by monocytes and fibroblasts, is a 
glycoprotein stimulating the bone marrow.[3] It also stimulates the 
survival, proliferation, differentiation, and function of neutrophil 
precursors and mature neutrophils with signal transduction 
pathways.[8] Patients with severe burn trauma often display 
significant impairments in cell-mediated immunity, including 
defective neutrophil chemotaxis, phagocytosis, and superoxide 
production, resulting in increased susceptibility to infection.[9] In 
some studies, it was shown that G-CSF is effective in reducing 
bacterial translocation and bacterial colonization and helps in 
wound healing.[10] Moreover, G-CSF angiogenesis property in 
endothelial cells (ECs) was determined in vitro and in vivo.[11,12] 
The results of the  Huang et al. (2017) study indicated that G-CSF 
angiogenic effects were enhanced in vitro.[13] Brubaker AL and 
Kovacs EJ et al. found that heightened bacterial colonization 
and delayed wound closure in aged mice could be attenuated by 
treatment with G-CSF.[14] Recently, evidence has suggested that 
G-CSF plays a tissue-protecting role and promotes tissue repair 
and regeneration in many injuries through anti-inflammatory 
capabilities of host’s cells.[15] However, the effects of G-CSF 
on wound size and its microscopic histological factors in burn 
injury have not been yet explicated clearly. Therefore, the aim 
of this study was to examine the histological effects of G-CSF 
on bacterial translocation in mice suffering from burn wound 
infection.
MAteRiAls And MethOds
This study was performed in two steps including in vitro and 
in vivo as follows:
In vitro step: Clinical isolates
In this step, MDR-Ab clinical isolates were used for inoculation 
of the wound in vivo. Ab strains were isolated from the burn 
wound of patients referred to Motahari Hospital Affiliated to 
Iran University of Medical Sciences.
In vivo step: Animal model
In this study, 18 adult Balb/c mice with the age ranging from 
18 to 20 months and mean weight of 20 ± 2 g were purchased 
from laboratory animals breeding center in Alborz Province. All 
animals were transferred to the breeding center of Iran University 
of Medical Sciences. All of which were maintained under the 
controlled environmental conditions, including room temperature 
of 32°C ± 2°C, relative humidity of 60%–70%, and photoperiod 
of 12 h light and 12 h dark. Food and water were available, and 
animals were randomly assigned into two groups of nine animals. 
All experimental techniques involving animals were approved by 
the Experimental Animal Ethics Committee of Iran University 
of Medical Sciences with IR.IUMS.REC1393.95474.
Induction of wounds and treatment procedure
The mice were anesthetized by an intraperitoneal 
i n j e c t i o n  o f  a  k e t a m i n e – x y l a z i n e  c o c k t a i l 
(ketamine 10 mg/kg + xylazine 4 mg/kg). Then, the dorsal 
area of all the animals was disinfected by 70% ethanol and 
shaved. The second-degree burns were induced on animals’ 
dorsal shaved area by a hot device like a circular steel rod 
(diameter = 2 cm and length = 20 cm) at 95°C for 8 s (setup by 
the research team). The dorsal area was dressed with a sterilized 
gas. After 24 h of burn induction, the wounds were inoculated 
by 0.1 mL of resistant Ab clinical isolates (1.5 × 108 CFU/mL).
Burn wound treatment
Twenty-four hours after induction of infection, all animals were 
randomly divided into two groups (n = 9 in each group). Burns 
in two groups were daily treated by subcutaneous injection 
(0.1 mL) in the area around the wound for 7 days following 
the burn wound infection by Ab as follows:
1. Group I (control) – Induction of burns on the skin + inoculated 
with 0.1 mL of resistant Ab clinical isolates + treatment by 
subcutaneous injections of normal saline (0.1 mL)
2. Group II (experimental) – Induction of burns on the 
skin + inoculated with 0.1 mL of resistant Ab clinical 
isolates + treatment by subcutaneous injections of 
G-CSF (10 µg/kg).
Evaluation of the wound healing process
All the animals were sacrificed using an overdose of xylazine, 
under anesthesia, 7 days after the start of treatment, and then, 
the extent of wound healing was evaluated.
Morphological assessment of burn wounds
The size of the burn wound was evaluated 24 h after the burn 
induction (before the start of treatment: day 0) and at the 3rd 
and 7th (last) days of posttreatment in two groups by measuring 
the wound’s surface area with naked eyes using a ruler.[16]
Histological assessment of burn wounds
After 7 days, animals were terminally anesthetized with xylazine, 
and 3 cm × 3 cm wound skin tissues were removed. The wound 
tissues were immediately fixed with 10% formalin and 8% NaCl, 
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and then, paraffin-embedded sections were prepared. The sections 
were cut by a microtome with 2 µm thickness and stained with 
hematoxylin and eosin (H and E) and  Masson’s Trichrome stains 
for light microscopy examinations.[13,17] The accuracy of collagen 
deposition scoring was increased by Masson’s trichrome stains.
[13,17] All specimens were evaluated by a pathologist who was blind 
to the tissue type. The main histological parameters included 
the amount of inflammation, re-epithelialization, angiogenesis, 
collagen deposition, the amount of granulation tissue, and 
fibroblast maturation. A histological scoring system, which was 
developed specifically for this study based on the scoring system 
suggested by Abramov et al., was used.[15,18] Accordingly, in this 
study, each histological parameter was assessed independently 
by assigning a score of 0–3 to it (0: none, 1: scant, 2: moderate, 
and 3: abundant). A paired sample t-test was used to compare 
the control and treatment groups.
Surgery and biopsy of tissue
A surgical biopsy was performed to evaluate the translocation and 
presence of white blood cells (WBCs) in the tissue. After removing 
the skin tissues and cutting the ventral area, the liver and spleen 
and ileum were removed. A part of the incisions was homogenized 
in a separate sterile plate containing 1 mL phosphate-buffered 
saline using the sterile scalpel method. Homogenized tissues 
were cultured on plates containing blood, and MacConkey agar 
was used for the observation and identification of Gram-negative 
microorganisms using standard microbiological methods. After 
24 h of incubation, all cultivated plates were checked to evaluate 
the bacterial growth and bacterial translocation.[17] The other parts 
of each tissue were transferred to 50 mL sterile tubes containing 
10% formalin and 8% NaCl and stored at 25°C for histological 
survey in terms of the presence of WBC. Comparisons between 
the groups were performed using the Chi-square test.
Tissue histology – Sample preparation
Tissue specimens were dehydrated by the tissue processing 
machine according to the manufacturer’s instruction. The 
dehydrated specimens were embedded in paraffin with a 
paraffin dispenser and cut by a microtome with 2 µm thickness. 
The thick sections were fixed on the slide and prepared for 
histopathology staining. Specimens were stained with H and E 
and checked for the presence or increased count of WBCs using 
a light microscope by a histologist. In this section, statistical 
analyses were performed using the Chi-square test.
Statistical analysis
Statistical analyses were performed using  Spss, version 
20, IBM Crop., Armonk, NY, USA. Comparisons between 
the control and treatment groups were performed using the 
paired-sample t-test and Chi-square test. A P < 0.05 was 
considered as statistically significant.
Results
Wound size examination
The mean size of the wound in the 3rd and 7th (last) days of 
the treatment was significantly reduced in the treatment group 
compared to that of the control group [Table 1].
Histological examination
After burn induction and treatment, histological parameters 
such as the amount of inflammation, re-epithelialization, 
angiogenesis, collagen deposition, the amount of granulation 
tissue, and fibroblast maturation were evaluated in burn 
wounds of all specimens. These parameters were evaluated 
based on the histological scoring system [Table 2].
As shown in Table 2 and Figure 1a-h, the level of inflammation 
was reduced in the G-CSF treated group. Moreover, the levels 
of re-epithelialization and collagen deposition were increased 
in this group compared to the normal saline-treated group but 
not statistically significant (P > 0.05).
Tissue histology – Bacterial translocation
To evaluate the bacterial translocation, homogenized liver and 
spleen tissues were cultured on microbial media.
Expectedly, in the G-CSF treated group, all mice showed 
significantly lower bacterial translocation compared with 
the control group (P = 0.02). The prevalence rates of the 
translocated organisms after wound burn infection in both 
groups are shown in Table 3.
Tissue histology – The presence of white blood cells
The amount of inflammation and the presence or increased 
count of WBCs in the G-CSF treated and control groups were 
measured using a light microscope. As shown in Table 4, there 
was no significant difference between the two groups regarding 
the WBC numbers in both liver and spleen tissues (P > 0.05).
discussiOn
Traumatic injury has a repressive effect on the immune system 
and decreased G-CSF, resulting in the increased susceptibility 
to infection.[19] It is specified that G-CSF could increase 
the number of circulating polymorphonuclear leukocytes 
in response to chemotactic peptides and help in wound 
closure.[16,20] Previous studies showed that burned patients 
with severe infections benefit from treatment by G-CSF.[21] In 
the present study, the beneficial effects of treatment by G-CSF 
on wound healing were demonstrated in male mice following 
wound infections caused by Ab strains. After burn induction 
in mice, the wound size was measured at the 3rd and 7th days; 
expectedly, the findings showed that the wound size in the 
Table 1: Mean of wound size  (36) after burn 
wound induction at the 3rd and 7th days of 
treatment in two groups  (normal saline group and 
granulocyte‑colony‑stimulating factor group), each with 
nine mice  (mean±standard deviation)
Groups Size of burn wound (mean±SD)
Third day Seventh day
Normal saline group 2.53±0.48* 2.15±0.32*
G-CSF group 1.08±0.55** 1.18±0.81**
*P=0.000, **P=0.01. G-CSF: Granulocyte-colony-stimulating factor, 
SD: Standard deviation
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G-CSF treated group was significantly lower than that in the 
control group. In this regard, the results of the present study 
are in line with other relevant studies. Furthermore, the results 
of the Fine et al. study indicated that G-CSF enhanced wound 
closure in 75.5% of the G-CSF treated patients. In their study, 
seven burned patients with severe infections were treated daily 
with subcutaneous G-CSF. After 7 days, all patients showed 
a significant reduction in a lesion size and blister or erosion 
counts.[21] Furthermore, in another similar study conducted 
by Brubaker and Kovacs, it was found that a wound size was 
reduced in the G-CSF-treated aged animals 3 and 7 days after 
the wound infection.[14,22]
As shown in Table 2 and Figure 1a-h, in this study, the level 
of inflammation was insignificantly reduced in the G-CSF 
treated group.
As expected, the findings of the present study are in line 
with those of other similar studies showing that G-CSF has 
Table 2: The survey of wound healing histologic parameters of the skin at the 7th day of treatment in burned mice
Groups Level of 
inflammation
Re-epithelialization Angiogenesis Collagen 
deposition




Normal saline group 1.85±1.06 0.42±0.53 1.42±1.39 1.14±0.89 2±1.41 1.28±1.11
G-CSF group 0.85±1.06 1.14±1.06 1±1 1.71±1.25 2±1.15 1.14±1.06
The effect of GCSF according to the scoring system at the 7th day of treatment in two groups (normal saline group and GCSF group) of nine
mice each (mean±SD). G-CSF: Granulocyte-colony-stimulating factor, SD: Standard deviation
Table 3:  Assessment of Bacterial translocation of enteric organisms after wound burn and infection based on the 
presence of bacteri in the liver and spleen
Organ Observation Count Groups Total
Control group G‑CSF group
Livera Presence of bacteria Count 3 0 3
Expected count 1.8 1.2 3.0
Absence of bacteria Count 6 6 12
Expected count 7.2 4.8 12.0
Total Count 9 6 15
Expected count 9.0 6.0 15.0
Spleenb Presence of bacteria Count 5 0 5
Expected count 3.0 2.0 5.0
Absence of bacteria Count 4 6 10
Expected count 6.0 4.0 10.0
Total Count 9 6 15
Expected count 9.0 6.0 15.0
Chi-square test: aValue: 2.5, df: 1, Significant: 0.11, b, Value: 5, df: 1, significant: 0.02. G-CSF: Granulocyte-colony-stimulating factor
Table 4: The survey of white blood cells  count in both of liver and spleen in the granulocyte-colony-stimulating factor 
treatment and control groups
Organ Observation Count Groups Total
Control group G‑CSF group
Livera Increased count of WBC Count 1 1 2
Expected count 1.1 0.9 2.0
No increase in the count of WBC Count 8 7 15
Expected count 7.9 7.1 15.0
Total Count 9 8 17
Expected count 9.0 8.0 17.0
Spleenb Increased count of WBC Count 0 1 1
Expected count 0.5 0.5 1.0
No increase in the count of WBC Count 9 7 16
Expected count 8.5 7.5 16.0
Total Count 9 8 17
Expected count 9.0 8.0 17.0
Chi-square test: aValue: 0.008, df: 1, significant: 0.92, bValue: 1.05, df: 1, significant: 0.3. WBC: White blood cell, G-CSF: Granulocyte-colony-stimulating 
factor
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therapeutic effects on tissue repair and regeneration, partly by 
ameliorating inflammation, re-epithelialization, and enhancing 
angiogenesis in various ischemic conditions.[23,24] In this 
regard, in a study conducted by  Hartung et al. (1998), G-CSF 
was introduced as an anti-inflammatory immunomodulator.
[25] Moreover, recent studies have shown that G-CSF could 
decrease inflammation by inhibiting the production or 
activity of the main inflammatory mediators, including 
interleukin (IL)-1 and interferon-gamma.[21,25,26] Furthermore, 
in 2016,   Liao et al. indicated that systemic G-CSF treatment 
after nerve injury could upregulate µ-opioid receptor in the 
injured nerve, And decrease peripheral nociceptive signals. 
This treatment could suppress the pro-inflammatory cytokines 
but enhance the anti-inflammatory cytokines, i.e., IL-4.[26]
These studies can partly confirm our study in relation to G-CSF 
anti-inflammatory effect.
In addition, in a study conducted in vitro and in vivo, it 
was observed that recombinant G-CSF could increase 
angiogenesis,[12,27] but in some studies and ours, it was shown 
that G-CSF decreases EC angiogenesis. Therefore, it is possible 
that the observation of angiogenesis following the prescription 
of G-CSF comes only due to the hematopoietic progenitor 
cells.[1,28] Because of the contradiction in these results, it seems 
that further studies are needed to be conducted.
In this study, it was also shown that G-CSF could reduce 
bacterial translocation in the G-CSF-treated group compared 
to the control group. Furthermore, the  Yalçin O et al. study 
showed that widespread use of G-CSF decreases bacterial 
translocation significantly.[10] The results of Hong-Fang 
et al. study indicated that G-CSF could enhance levels of the 
opsonin receptors, CD11b and CD32/16, which are necessary 
for antimicrobial function and provided protection against 
infection in animal models of severe acute pancreatitis.[29]
Although the role of G-CSF in reducing inflammation and 
infection of wound is under investigation, it seems that G-CSF 
can accelerate bacterial clearance and ameliorate inflammation 
by improving immune system and neutrophil function in the 
sites of inflamed wound.[14,30]
In a recent study performed by this research team, it was found 
that G-CSF could elevate the number of circulating leukocytes,[31] 
while there was no significant difference between the groups 
regarding the number of tissue-derived WBCs. According to 
the effect of G-CSF on bacterial translocation, it was found that 
G-CSF preferably enhances bactericidal activity. In addition, 
regarding the effects of G-CSF in patients with neutropenia[32] as 
well as donors before hematopoietic stem cell transplantation,[32] 
it seems that the use of G-CSF may be functional in infectious 
wound, where neutrophils are absent or dysfunctional.
cOnclusiOn
The findings of the present study reveal that G-CSF could 
enhance wound closure. Furthermore, it was shown that G-CSF 
has an anti-inflammatory role in wound healing and reduces 
bacterial translocation. Together, these reports provided novel 
indications for the use of G-CSF as therapeutic interventions.
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